KIR and HLA in cis and trans cooperatively shape human NK education
顺式和反式的 KIR 和 HLA 合作塑造人类 NK 教育
基本信息
- 批准号:9310137
- 负责人:
- 金额:$ 42.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-03 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acute leukemiaAffinityAllogenicAllograftingBindingBone MarrowCD34 geneCell TherapyCell TransplantsCell surfaceCellsChimera organismDevelopmentDiseaseDonor SelectionEducationEnergy TransferEngraftmentEnvironmentEvaluationExhibitsExposure toFailureGene FamilyGeneticGoalsHLA AntigensHematologic NeoplasmsHematopoieticHematopoietic Stem Cell TransplantationHistocompatibility Antigens Class IHumanImmuneImmune systemImmunityImmunogeneticsImmunologyIn VitroInflammatoryInnate Immune SystemInterruptionInvestigationKnowledgeLicensingLigandsLigationLymphocyteMediatingMembraneMissionMolecularMonoclonal AntibodiesMouse StrainsMusNatural Killer CellsPatientsPlayPopulationProteinsPublic HealthRNA InterferenceRelapseResearchRoleSamplingShapesSolidStem cellsStudy SubjectSystemTechnologyTestingTransgenic MiceTransgenic OrganismsTransplant RecipientsTransplantationUmbilical Cord BloodUnited States National Institutes of HealthVirusVirus Diseasescancer cellcancer therapyclinically relevantcytotoxicityhematopoietic cell transplantationhumanized mousein vivoin vivo Modelkillingsleukemiamouse modelnon-Nativenovelreceptorrelapse riskresponsetherapy designtumor
项目摘要
PROJECT SUMMARY
Natural Killer (NK) cells are highly relevant in the setting of hematopoietic stem cell transplantation (HCT),
where their activity can drastically reduce the risk of relapse in leukemia patients. Despite advances in donor
selection to minimize transplant complications, leukemia relapse remains one of the most devastating causes
of transplant failure. There is a general lack of knowledge of how NK cell populations are educated for effector
function, leukemia recognition and clearance. While it is known that interaction between HLA class I molecules
and the inhibitory killer Ig-like receptors (KIR) are important for NK education or “licensing” for effector function,
the orientation of their interaction, the factors that contribute to the strength of their interaction, and the relative
contributions of donor and recipient HLA are not known.
A major impediment to fundamental human NK studies has been the lack of in vivo models that
faithfully recapitulate NK education. A humanized NOD-RAG2IL2Rγc-/- mouse strain that exhibits HLA-B*27:05
successfully permits engraftment of mature NK cells and development of functional human NK cells from
CD34+ stem cells. Preliminary investigations reveal that in vivo environments expressing cognate HLA educate
developing and transferred KIR-expressing NK cells and enhance their long-term survival. In parallel, FRET
and RNAi technology reveals that cis-interaction between HLA and KIR intrinsic to the cell also facilitates NK
education. Evidence that HLA molecules can be transferred onto NK cells from adjacent cells provokes
investigation of trogocytosis as a mechanism by which trans HLA may permit education via cis ligation of KIR.
Restriction of HLA expression to the hematopoietic or stromal compartments in bone marrow chimeras
will help define the relative contributions of donor and recipient HLA to NK licensing and persistence. Receptor-
ligand pairs known to bind in trans also interact in cis, and further clarification is required to understand how
these interactions influence NK function. Competition between cis-trans binding will test the hypothesis that cis
interactions facilitate NK responsiveness by shielding KIR from ligation of trans HLA. NK cells with and without
non-native HLA expression will be functionally tested to better understand how trogocytosis contributes to NK
education after continuous or interrupted exposure to cognate HLA. Finally, experimental findings from the
humanized mouse model and in vitro studies will be verified in a fully human system using NK cells obtained
from patients who have received an HLA-mismatched umbilical cord blood transplant.
These goals will advance our understanding of fundamental molecular requirements for NK education
and acquisition of effector function. A deeper understanding of licensing by HLA provided in cis and trans will
inform donor selection in hematopoietic cell transplantation and adoptive NK cell therapies for the treatment of
cancer.
项目摘要
天然杀伤(NK)细胞在造血干细胞移植(HCT)的情况下高度相关
他们的活性可以大大减少白血病患者复发的风险。
选择以最大程度地减少移植并发症,白血病复发仍然是最偏差的因果关系之一
透明失败。
功能,白血病识别和清除。
抑制性杀手Ig般的受体(KIR)对于NK教育或“许可”对于效果功能很重要,
它们相互作用的方向,导致相互作用强度的因素以及相对
捐助者和接受者HLA的贡献尚不清楚。
基本人类NK研究的主要阻碍是缺乏体内模型
忠实地向NK教育进行了重组。
成功允许英语NK细胞和功能性人NK细胞的发展
CD34+干细胞。
开发和转移了表达KIR的NK细胞,并在并行中增强了其长期生存
RNAi技术揭示了HLA和KIR固有的CIS相互作用也有助于NK
教育。
将trogocytosis的调查作为一种机制,可以通过trans HLA允许通过KIR的顺式结扎进行教育。
HLA表达对骨髓嵌合体中造血或基质室的限制
将有助于定义捐助者和接受者HLA对NK许可和持久性的相对贡献。
已知在Transo结合的配体对也在顺式中相互作用,需要进一步澄清才能了解如何理解
这些相互作用会影响NK功能。
相互作用可以通过有或不带有trans HLA结扎的KIR来促进NK的疾病。
非本地HLA表达将进行功能测试,以更好地了解Trogotictis如何有助于NK
持续或中断接触同源HLA后的教育。
人性化小鼠模型和体外研究将在完全人类的系统中使用获得的NK细胞进行验证
从接受过HLA不匹配的脐带血移植的患者。
这些目标将提高我们对NK教育基本分子要求的理解
并获得效应函数。
在造血细胞移植和收养NK细胞疗法中为供体选择提供信息
癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHARINE C HSU其他文献
KATHARINE C HSU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHARINE C HSU', 18)}}的其他基金
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
HCMV 诱导的先天样 CD8 T 细胞和同种异体 HCT 结果
- 批准号:
10390447 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
机器学习与免疫遗传学预测造血细胞移植结果
- 批准号:
10322105 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
HCMV 诱导的先天样 CD8 T 细胞和同种异体 HCT 结果
- 批准号:
10590647 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
机器学习与免疫遗传学预测造血细胞移植结果
- 批准号:
10534187 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Natural killer cell and T-cell crosstalk in CMV infection
CMV 感染中的自然杀伤细胞和 T 细胞串扰
- 批准号:
9398188 - 财政年份:2017
- 资助金额:
$ 42.85万 - 项目类别:
KIR and HLA in cis and trans cooperatively shape human NK education
顺式和反式的 KIR 和 HLA 合作塑造人类 NK 教育
- 批准号:
9160652 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma
人源化 3F8 MoAb (IND 112594) 和 NK 细胞 (IND BB-13399) 治疗神经母细胞瘤的 I 期研究
- 批准号:
9488351 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
基于KIR和HLA基因型的同种异体造血细胞供体选择
- 批准号:
9271228 - 财政年份:2015
- 资助金额:
$ 42.85万 - 项目类别:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
基于KIR和HLA基因型的同种异体造血细胞供体选择
- 批准号:
8865414 - 财政年份:2015
- 资助金额:
$ 42.85万 - 项目类别:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
神经母细胞瘤的联合免疫治疗:先天肿瘤免疫模型
- 批准号:
8508896 - 财政年份:2012
- 资助金额:
$ 42.85万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Enhancing CAR T Cell Homing Through Glycoengineering
通过糖工程增强 CAR T 细胞归巢
- 批准号:
10577107 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
利用造血干细胞衍生的初始 CAR T 细胞利用胸腺来长期控制肿瘤
- 批准号:
10365031 - 财政年份:2022
- 资助金额:
$ 42.85万 - 项目类别:
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
利用造血干细胞衍生的初始 CAR T 细胞利用胸腺来长期控制肿瘤
- 批准号:
10580801 - 财政年份:2022
- 资助金额:
$ 42.85万 - 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
- 批准号:
10394937 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
- 批准号:
10609407 - 财政年份:2021
- 资助金额:
$ 42.85万 - 项目类别: